Axsome Therapeutics, Inc. Quarterly Goodwill in USD from Q2 2022 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.
Summary
Axsome Therapeutics, Inc. quarterly Goodwill history and growth rate from Q2 2022 to Q3 2024.
  • Axsome Therapeutics, Inc. Goodwill for the quarter ending September 30, 2024 was $12M, unchanged year-over-year.
Goodwill, Quarterly (USD)
Goodwill, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $12M $0 0% Sep 30, 2024 10-Q 2024-11-12
Q2 2024 $12M $0 0% Jun 30, 2024 10-Q 2024-08-05
Q1 2024 $12M +$1.73M +16.8% Mar 31, 2024 10-Q 2024-05-06
Q4 2023 $12M +$1.73M +16.8% Dec 31, 2023 10-Q 2024-11-12
Q3 2023 $12M +$145K +1.22% Sep 30, 2023 10-Q 2023-11-06
Q2 2023 $12M +$145K +1.22% Jun 30, 2023 10-Q 2023-08-07
Q1 2023 $10.3M Mar 31, 2023 10-Q 2023-05-09
Q4 2022 $10.3M Dec 31, 2022 10-K 2024-02-23
Q3 2022 $11.9M Sep 30, 2022 10-Q 2022-11-07
Q2 2022 $11.9M Jun 30, 2022 10-Q 2022-08-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.